Literature DB >> 1394166

Does chronic fatigue syndrome predispose to non-Hodgkin's lymphoma?

P H Levine1, D Peterson, F L McNamee, K O'Brien, G Gridley, M Hagerty, J Brady, T Fears, M Atherton, R Hoover.   

Abstract

Chronic fatigue syndrome, an illness that frequently is associated with abnormalities of cellular immunity, has been reported anecdotally to be associated with an increased incidence of lymphoid hyperplasia and malignancy. This report describes an initial analysis of population-based cancer incidence data in Nevada, focusing on the patterns of non-Hodgkin's lymphoma prior to and subsequent to well described, documented outbreaks of chronic fatigue syndrome during 1984-1986. In a study of time trends in four age groups, the observed time trends were consistent with the national trends reported in the Surveillance, Epidemiology, and End Results Program. No statistically significant increase attributable to the chronic fatigue syndrome outbreak was identified at the state level. Additional studies are in progress analyzing the data at the country level, reviewing patterns in other malignancies, and continuing to monitor the cancer patterns over subsequent years.

Entities:  

Mesh:

Year:  1992        PMID: 1394166

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.

Authors:  Cindy M Chang; Joan L Warren; Eric A Engels
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

2.  Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.

Authors:  Alicia K Smith; Hong Fang; Toni Whistler; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  Neuropsychobiology       Date:  2011-09-09       Impact factor: 2.328

Review 3.  Inflammatory breast cancer clusters: A hypothesis.

Authors:  Paul H Levine; Salman Hashmi; Ashley A Minaei; Carmela Veneroso
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 5.  An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.

Authors:  Michael J Wells; Steven Jacobson; Paul H Levine
Journal:  Infect Agent Cancer       Date:  2019-11-05       Impact factor: 2.965

6.  The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).

Authors:  Derek F H Pheby; Diana Araja; Uldis Berkis; Elenka Brenna; John Cullinan; Jean-Dominique de Korwin; Lara Gitto; Dyfrig A Hughes; Rachael M Hunter; Dominic Trepel; Xia Wang-Steverding
Journal:  Medicina (Kaunas)       Date:  2021-04-16       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.